After initially stating its WLFI token would remain non-tradable, the Trump-linked crypto project now says a transfer function is in the works — signaling a possible pivot to public trading.

Fresh from their Download headline debut, it’s looking like Sleep Token are on the new soundtrack for Death Stranding 2: On The Beach. Ahead of Hideo Kojima’s new game’s arrival on ...

The KOL presentation will review Arcturus’ interim clinical data from ARCT-810 Phase 2 trials evaluating the safety and pharmacodynamics of multiple doses of ARCT-810 in adolescent and adult ...

Aaron Guzikowski (Raised by Wolves) has signed to write the screenplay for an adult-targeted animated feature inspired by Hideo Kojima ’s hit action-adventure video game Death Stranding. The ...

Polyhedra and Binance confirmed several abnormal transactions involving the ZKJ/KOGE trading pair triggered a liquidation cascade in Polyhedra’s ZKJ token.

Want to discover the next big crypto token before it launches? Learn how to use top launchpads like Best Wallet, DexScreener, and Raydium to spot early-stage projects across Solana, Ethereum, and BSC.

Outstanding Animated Program Commentary (Updated: June 5, 2025): After seven acclaimed seasons and more than 50 Emmy nominations, “Big Mouth” could finally claim the trophy for Outstanding ...

This week the lore-rich, genre-smashing, entirely anonymous hard-rock band Sleep Token lands its first-ever No. 1 album. Elsewhere, on the Hot 100 singles chart, Kendrick Lamar's "Luther (feat ...

English rock band Sleep Token earns its first No. 1 album with ‘Even in Arcadia’; Kali Uchis' 'Sincerely' debuts at No. 2.

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work in an effort to prioritize spending and extend its cash runway. | San ...

‘CoComelon’ Animated Movie in the Works Universal Pictures will release the film based on the popular kids show in theaters in 2027.

Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of 67.09% and 3.10%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?